drugset / Trial / NCT06319131
Nadroparin Versus TIPS in Cirrhotic Patients With Refractory Asymptomatic PVT
Unknown
84 enrolled
Shanghai Zhongshan Hospital
Renmin Hospital of Wuhan University · collabShanghai 6th People's Hospital · collabShuGuang Hospital · collabTongji Hospital · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to evaluate the comparative effectiveness of nadroparin versus transjugular intrahepatic portosystemic shunt in cirrhotic patients with refractory asymptomatic portal vein thrombosis using a design of a multicenter, randomized controlled trial
Timeline
- Start
- 2024-05-01
- Primary completion
- 2025-05-30
- Completion
- 2026-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Nadroparin Calcium | Other / unclassified | 85 iu/kg | Subcutaneous |